DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sorich MJ. et al.
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials.
Ann Oncol 2015;
26: 13-21
We do not assume any responsibility for the contents of the web pages of other providers.